Ai-assisted nucleic acid-ligand interaction prediction in gene regulation

Technology
Conceptual
Company

An innovative AI-driven approach leveraging nucleic acid language models and protein-ligand interaction models to predict genome interactions for gene regulation. This technology aims to enhance precision in altering genetic outcomes through advanced model development.

Overview

This solution focuses on AI-assisted prediction of nucleic acid-ligand interactions, crucial for gene regulation. By utilizing transformer-based AI architectures, the technology seeks to identify genome regions and small molecule interactions that influence genetic outcomes. The aim is to shift equilibrium observations towards desired gene regulatory outcomes, offering potential breakthroughs in genetic research and therapeutic applications.

Technical specifications

The approach integrates multiple AI models:

  • Nucleic acid language models to understand complex genetic sequences.
  • Reaction prediction models to anticipate molecular interactions.
  • Protein-ligand interaction models to elucidate binding effects on gene expression.

The process involves data assessment, model building and selection, fine-tuning for resolution, and iterative data collection for enhancing model accuracy. The ultimate goal is to achieve robust predictive or generative capabilities, allowing for precise genetic modulation.

Technology readiness level

Currently at TRL 2, this technology is in the early stages of development, with ongoing efforts to validate existing data and refine AI models for improved prediction accuracy and applicability in gene regulation.


About Omics Archive

Omics Archive is a biotechnology company that integrates artificial intelligence, blockchain, and synthetic biology to advance sustainable biomanufacturing. The company provides a platform that utilizes federated learning to allow AI developers to train models on proprietary and in-house omics and digital sequence datasets while maintaining data privacy. By leveraging blockchain technology, the platform enables the conversion of omics data and digital sequences into tradable assets, supporting a marketplace for data licensing, generation funding, and trading stakes in datasets.

This integrated approach aims to accelerate data-driven discoveries and innovations in the biotechnology sector. The platform offers services that support the decentralized management of data assets and the operational needs of autonomous biomanufacturing plants. By providing tools for researchers and businesses to navigate microbial omics data, Omics Archive seeks to enhance the velocity and marketability of synthetic biology initiatives, facilitating more efficient research and development cycles for biotech start-ups.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.